MarketPeel
OL

OrbiMed Genesis GP LLC

ACET
DIRECTOR · ADICET BIO, INC. · CIK 0001808744
FILING MIX · LIFETIME42%/58%
BUYS
112
SELLS
156
TOTAL VALUE
$416.23M
COMPANIES
18
ACTIVE SINCE
Apr 2020
HOLDINGS NOW
54,020,322
AVG SELL PX
$17.62
TRADE KIND
SHOWING 268 / 268
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
81 backtested trades · 8 horizons · 44 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by OrbiMed Genesis GP LLC, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d81+72.84%+1.34%-0.12%+1.46%-0.50%1.39
14d81+70.37%+1.45%-0.77%+2.22%-2.10%1.13
30d81+70.37%-9.64%-1.69%-7.95%-11.53%-3.88
60d81+62.96%-4.84%+1.97%-6.82%-10.65%-3.27
90d81+71.60%-2.49%+4.34%-6.83%-10.05%-2.65
180d81+45.68%+2.59%+9.32%-6.74%-3.71%-1.45
1y81(4 pending)+45.45%+18.60%+14.19%+4.41%-6.59%0.47
2y81(40 pending)+48.57%-7.62%+32.15%-39.50%-49.86%-3.59
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.

Dollar flow by company · 4 months

Open-market Form 4 flow · derivatives and mechanical transactions excluded

2 / 0
1,940,000
+$34.9M
07+$008+$34.9M09+$010+$0
2026-08-07 → 2026-08-07
2 / 0
1,333,333
+$20.0M
07+$008+$009+$20.0M10+$0
2026-09-21 → 2026-09-21
3 / 0
950,000
+$16.1M
07+$008+$009+$16.1M10+$0
2026-09-28 → 2026-09-28
Holdings over time
ACET · 0 shares · as of Apr 8, 2026
02,256,5904,513,1806,769,7699,026,35920222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 100 buys / 144 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ADRX
ADARX PHARMACEUTICALS, INC.
PURCHASE
588,235$17.00$10.00M588,235Sep 28, 2026Sep 30, 2026 ↗View →
ADRX
ADARX PHARMACEUTICALS, INC.
DISPOSE (DERIVATIVE)
564,187——0Sep 28, 2026Sep 30, 2026 ↗View →
ADRX
ADARX PHARMACEUTICALS, INC.
ACQUIRE
256,448——9,230,509Sep 28, 2026Sep 30, 2026 ↗View →
ADRX
ADARX PHARMACEUTICALS, INC.
ACQUIRE
1,333,975——8,460,994Sep 28, 2026Sep 30, 2026 ↗View →
ADRX
ADARX PHARMACEUTICALS, INC.
PURCHASE
61,516$17.00$1.05M9,292,025Sep 28, 2026Sep 30, 2026 ↗View →
ADRX
ADARX PHARMACEUTICALS, INC.
ACQUIRE
2,000,962——12,691,492Sep 28, 2026Sep 30, 2026 ↗View →
ADRX
ADARX PHARMACEUTICALS, INC.
ACQUIRE
564,187——14,025,280Sep 28, 2026Sep 30, 2026 ↗View →
ADRX
ADARX PHARMACEUTICALS, INC.
DISPOSE (DERIVATIVE)
7,127,019——0Sep 28, 2026Sep 30, 2026 ↗View →
ADRX
ADARX PHARMACEUTICALS, INC.
DISPOSE (DERIVATIVE)
513,067——0Sep 28, 2026Sep 30, 2026 ↗View →
ADRX
ADARX PHARMACEUTICALS, INC.
ACQUIRE
513,067——8,974,061Sep 28, 2026Sep 30, 2026 ↗View →
ADRX
ADARX PHARMACEUTICALS, INC.
ACQUIRE
769,601——13,461,093Sep 28, 2026Sep 30, 2026 ↗View →
ADRX
ADARX PHARMACEUTICALS, INC.
DISPOSE (DERIVATIVE)
1,333,975——0Sep 28, 2026Sep 30, 2026 ↗View →
ADRX
ADARX PHARMACEUTICALS, INC.
PURCHASE
300,249$17.00$5.10M14,325,529Sep 28, 2026Sep 30, 2026 ↗View →
ADRX
ADARX PHARMACEUTICALS, INC.
ACQUIRE
7,127,019——7,127,019Sep 28, 2026Sep 30, 2026 ↗View →
ADRX
ADARX PHARMACEUTICALS, INC.
DISPOSE (DERIVATIVE)
2,000,962——0Sep 28, 2026Sep 30, 2026 ↗View →
ADRX
ADARX PHARMACEUTICALS, INC.
DISPOSE (DERIVATIVE)
769,601——0Sep 28, 2026Sep 30, 2026 ↗View →
ADRX
ADARX PHARMACEUTICALS, INC.
DISPOSE (DERIVATIVE)
256,448——0Sep 28, 2026Sep 30, 2026 ↗View →
ADRX
ADARX PHARMACEUTICALS, INC.
ACQUIRE
10,690,530——10,690,530Sep 28, 2026Sep 30, 2026 ↗View →
ADRX
ADARX PHARMACEUTICALS, INC.
DISPOSE (DERIVATIVE)
10,690,530——0Sep 28, 2026Sep 30, 2026 ↗View →
ETRA
ELECTRA THERAPEUTICS, INC.
ACQUIRE
1,087,934——3,090,244Sep 21, 2026Sep 23, 2026 ↗View →
ETRA
ELECTRA THERAPEUTICS, INC.
PURCHASE
333,333$15.00$5.00M5,126,891Sep 21, 2026Sep 23, 2026 ↗View →
ETRA
ELECTRA THERAPEUTICS, INC.
DISPOSE (DERIVATIVE)
758,279——0Sep 21, 2026Sep 23, 2026 ↗View →
ETRA
ELECTRA THERAPEUTICS, INC.
ACQUIRE
758,279——758,279Sep 21, 2026Sep 23, 2026 ↗View →
ETRA
ELECTRA THERAPEUTICS, INC.
DISPOSE (DERIVATIVE)
2,002,310——0Sep 21, 2026Sep 23, 2026 ↗View →
ETRA
ELECTRA THERAPEUTICS, INC.
PURCHASE
1,000,000$15.00$15.00M1,758,279Sep 21, 2026Sep 23, 2026 ↗View →
ETRA
ELECTRA THERAPEUTICS, INC.
DISPOSE (DERIVATIVE)
1,703,314——0Sep 21, 2026Sep 23, 2026 ↗View →
ETRA
ELECTRA THERAPEUTICS, INC.
ACQUIRE
1,703,314——4,793,558Sep 21, 2026Sep 23, 2026 ↗View →
ETRA
ELECTRA THERAPEUTICS, INC.
DISPOSE (DERIVATIVE)
1,087,934——0Sep 21, 2026Sep 23, 2026 ↗View →
ETRA
ELECTRA THERAPEUTICS, INC.
ACQUIRE
2,002,310——2,002,310Sep 21, 2026Sep 23, 2026 ↗View →
BRVE
BRAVEHEART BIO, INC.
SALE
40,000,000——0Aug 7, 2026Aug 11, 2026 ↗View →
BRVE
BRAVEHEART BIO, INC.
PURCHASE
273,333$18.00$4.92M273,333Aug 7, 2026Aug 11, 2026 ↗View →
BRVE
BRAVEHEART BIO, INC.
PURCHASE
1,666,667$18.00$30.00M11,901,826Aug 7, 2026Aug 11, 2026 ↗View →
BRVE
BRAVEHEART BIO, INC.
PURCHASE
9,132,420——10,235,159Aug 7, 2026Aug 11, 2026 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
1,477$45.00$66.5K219,405Jun 22, 2026Jun 22, 2026 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
24,846$45.38$1.13M220,882Jun 22, 2026Jun 22, 2026 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
787,024$45.38$35.72M6,601,878Jun 22, 2026Jun 22, 2026 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
46,776$45.00$2.10M6,555,102Jun 22, 2026Jun 22, 2026 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
272,322$45.02$12.26M7,388,902Jun 15, 2026Jun 17, 2026 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
9,086$45.02$409.1K245,728Jun 15, 2026Jun 17, 2026 ↗View →
STTK
SHATTUCK LABS, INC.
PURCHASE
1,041,667——26,519,541Jun 11, 2026Jun 15, 2026 ↗View →
STTK
SHATTUCK LABS, INC.
PURCHASE
208,333——5,303,908Jun 11, 2026Jun 15, 2026 ↗View →
STTK
SHATTUCK LABS, INC.
SALE
15,366,490——0Jun 8, 2026Jun 9, 2026 ↗View →
STTK
SHATTUCK LABS, INC.
PURCHASE
3,073,298——5,095,575Jun 8, 2026Jun 9, 2026 ↗View →
STTK
SHATTUCK LABS, INC.
SALE
3,073,298——0Jun 8, 2026Jun 9, 2026 ↗View →
STTK
SHATTUCK LABS, INC.
PURCHASE
15,366,490——25,477,874Jun 8, 2026Jun 9, 2026 ↗View →
QTTB
Q32 BIO INC.
PURCHASE
1,250,000$8.00$10.00M3,502,987May 28, 2026Jun 1, 2026 ↗View →
QTTB
Q32 BIO INC.
PURCHASE
625,000$8.00$5.00M625,000May 28, 2026Jun 1, 2026 ↗View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASE
1,689,189$4.44$7.50M11,808,945Apr 21, 2026Apr 23, 2026 ↗View →
PRLD
PRELUDE THERAPEUTICS INC
PURCHASE
1,126,126$4.44$5.00M1,126,126Apr 21, 2026Apr 23, 2026 ↗View →
IMA
IMAGENEBIO, INC.
PURCHASE
336,603——336,603Apr 14, 2026Apr 16, 2026 ↗View →
IMA
IMAGENEBIO, INC.
PURCHASE
384,689——384,689Apr 14, 2026Apr 16, 2026 ↗View →
ACET
ADICET BIO, INC.
SALE
32,523$6.29$204.6K0Apr 8, 2026Apr 9, 2026 ↗View →
ACET
ADICET BIO, INC.
SALE
40,416$6.52$263.5K0Apr 8, 2026Apr 9, 2026 ↗View →
ACET
ADICET BIO, INC.
SALE
2,400$6.38$15.3K32,523Apr 7, 2026Apr 9, 2026 ↗View →
ACET
ADICET BIO, INC.
SALE
29,319$6.53$191.5K34,923Apr 7, 2026Apr 9, 2026 ↗View →
KROS
KEROS THERAPEUTICS, INC.
SALE
140,057$17.75$2.49M759,155Nov 21, 2025Dec 18, 2025 ↗View →
KROS
KEROS THERAPEUTICS, INC.
SALE
74,465$17.75$1.32M45,057Nov 21, 2025Dec 18, 2025 ↗View →
ACET
ADICET BIO, INC.
PURCHASE
1,500,000$1.00$1.50M9,026,359Oct 8, 2025Oct 10, 2025 ↗View →
ACET
ADICET BIO, INC.
PURCHASE
3,500,000$1.00$3.50M4,490,254Oct 8, 2025Oct 10, 2025 ↗View →
STTK
SHATTUCK LABS, INC.
PURCHASE
10,111,384——10,111,384Aug 25, 2025Sep 2, 2025 ↗View →
STTK
SHATTUCK LABS, INC.
PURCHASE
5,255,106$0.87$4.56M5,255,106Aug 25, 2025Sep 2, 2025 ↗View →
STTK
SHATTUCK LABS, INC.
PURCHASE
2,022,277——2,022,277Aug 25, 2025Sep 2, 2025 ↗View →
STTK
SHATTUCK LABS, INC.
PURCHASE
3,073,298——3,073,298Aug 25, 2025Sep 2, 2025 ↗View →
STTK
SHATTUCK LABS, INC.
PURCHASE
15,366,490——15,366,490Aug 25, 2025Sep 2, 2025 ↗View →
STTK
SHATTUCK LABS, INC.
PURCHASE
1,051,021$0.87$912.0K1,051,021Aug 25, 2025Sep 2, 2025 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
SALE
3,571,428$1.59$5.68M0Apr 9, 2025Apr 11, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
124,193$20.13$2.50M443,792Apr 3, 2025Apr 4, 2025 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
372,578$20.13$7.50M14,809,075Apr 3, 2025Apr 4, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
756$54.11$40.9K186,541Mar 24, 2025Mar 26, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
3,026$54.11$163.7K746,171Mar 24, 2025Mar 26, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
1,956$54.11$105.8K482,308Mar 24, 2025Mar 26, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
5,279$54.00$285.1K749,197Mar 21, 2025Mar 21, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
3,412$54.00$184.2K484,264Mar 21, 2025Mar 21, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
1,320$54.00$71.3K187,297Mar 21, 2025Mar 21, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
941$54.01$50.8K487,676Mar 20, 2025Mar 21, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
364$54.01$19.7K188,617Mar 20, 2025Mar 21, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
1,457$54.01$78.7K754,476Mar 20, 2025Mar 21, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
20,911$54.02$1.13M755,933Mar 19, 2025Mar 21, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
5,228$54.02$282.4K188,981Mar 19, 2025Mar 21, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
13,517$54.02$730.2K488,617Mar 19, 2025Mar 21, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
233$55.05$12.8K204,942Mar 12, 2025Mar 12, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
27,750$54.44$1.51M502,134Mar 12, 2025Mar 12, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
933$55.05$51.4K819,774Mar 12, 2025Mar 12, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
42,930$54.44$2.34M776,844Mar 12, 2025Mar 12, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
603$55.05$33.2K529,884Mar 12, 2025Mar 12, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
10,733$54.44$584.3K194,209Mar 12, 2025Mar 12, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
14,267$54.01$770.6K820,707Mar 11, 2025Mar 12, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
9,222$54.01$498.1K530,487Mar 11, 2025Mar 12, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
3,567$54.01$192.7K205,175Mar 11, 2025Mar 12, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
26,596$54.29$1.44M208,795Mar 10, 2025Mar 12, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
53$55.01$2.9K208,742Mar 10, 2025Mar 12, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
106,384$54.29$5.78M835,185Mar 10, 2025Mar 12, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
136$55.01$7.5K539,709Mar 10, 2025Mar 12, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
211$55.01$11.6K834,974Mar 10, 2025Mar 12, 2025 ↗View →
IRON
DISC MEDICINE, INC.
SALE
68,766$54.29$3.73M539,845Mar 10, 2025Mar 12, 2025 ↗View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
94,100$10.84$1.02M747,887Feb 18, 2025Feb 19, 2025 ↗View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
49,070$10.84$531.9K3,255,000Feb 18, 2025Feb 19, 2025 ↗View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
17,962$9.90$177.8K3,176,390Feb 14, 2025Feb 19, 2025 ↗View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
29,540$9.85$291.0K3,205,930Feb 14, 2025Feb 19, 2025 ↗View →
MBX
MBX BIOSCIENCES, INC.
SALE
12,372,634——0Sep 16, 2024Sep 17, 2024 ↗View →
MBX
MBX BIOSCIENCES, INC.
SALE
4,854,368——0Sep 16, 2024Sep 17, 2024 ↗View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
403,787——403,787Sep 16, 2024Sep 17, 2024 ↗View →
MBX
MBX BIOSCIENCES, INC.
SALE
19,587,284——0Sep 16, 2024Sep 17, 2024 ↗View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
500,000$16.00$8.00M3,158,428Sep 16, 2024Sep 17, 2024 ↗View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
2,658,428——2,658,428Sep 16, 2024Sep 17, 2024 ↗View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
250,000$16.00$4.00M653,787Sep 16, 2024Sep 17, 2024 ↗View →
KROS
KEROS THERAPEUTICS, INC.
SALE
29,400$44.01$1.29M119,522Aug 13, 2024Aug 15, 2024 ↗View →
KROS
KEROS THERAPEUTICS, INC.
SALE
220,600$44.01$9.71M899,212Aug 13, 2024Aug 15, 2024 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
556$10.00$5.6K1,967,924Jul 16, 2024Jul 17, 2024 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
623$10.00$6.2K755,635Jul 16, 2024Jul 17, 2024 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
4,009$10.00$40.1K4,839,412Jul 16, 2024Jul 17, 2024 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
6,142$10.00$61.4K756,258Jul 15, 2024Jul 17, 2024 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
5,401$10.00$54.0K1,968,480Jul 15, 2024Jul 17, 2024 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
39,433$10.00$394.3K4,843,421Jul 15, 2024Jul 17, 2024 ↗View →
IRON
DISC MEDICINE, INC.
PURCHASE
43,944$36.00$1.58M941,569Jun 17, 2024Jun 20, 2024 ↗View →
IRON
DISC MEDICINE, INC.
PURCHASE
10,986$36.00$395.5K235,391Jun 17, 2024Jun 20, 2024 ↗View →
IRON
DISC MEDICINE, INC.
PURCHASE
28,404$36.00$1.02M608,611Jun 17, 2024Jun 20, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
1,000,000$22.14$22.14M7,663,349May 16, 2024May 20, 2024 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
33,300$22.14$737.3K254,814May 16, 2024May 20, 2024 ↗View →
ACET
ADICET BIO, INC.
PURCHASE
1,041,700$2.40$2.50M1,255,985Jan 25, 2024Jan 26, 2024 ↗View →
ACET
ADICET BIO, INC.
PURCHASE
242,200$2.40$581.3K990,254Jan 25, 2024Jan 26, 2024 ↗View →
ACET
ADICET BIO, INC.
PURCHASE
1,841,100$2.40$4.42M7,526,359Jan 25, 2024Jan 26, 2024 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
454,545$11.00$5.00M14,436,497Jan 23, 2024Jan 25, 2024 ↗View →
IRON
DISC MEDICINE, INC.
SALE
1,724$59.24$102.1K0Dec 18, 2023Dec 20, 2023 ↗View →
IRON
DISC MEDICINE, INC.
SALE
1,724——0Dec 18, 2023Dec 20, 2023 ↗View →
IRON
DISC MEDICINE, INC.
PURCHASE
1,724$38.00$65.5K1,724Dec 18, 2023Dec 20, 2023 ↗View →
IRON
DISC MEDICINE, INC.
SALE
100$57.73$5.8K1,126,125Dec 14, 2023Dec 14, 2023 ↗View →
IRON
DISC MEDICINE, INC.
SALE
100$57.73$5.8K727,807Dec 14, 2023Dec 14, 2023 ↗View →
IRON
DISC MEDICINE, INC.
SALE
57,100$56.75$3.24M224,405Dec 14, 2023Dec 15, 2023 ↗View →
IRON
DISC MEDICINE, INC.
SALE
147,600$56.75$8.38M580,207Dec 14, 2023Dec 15, 2023 ↗View →
IRON
DISC MEDICINE, INC.
SALE
228,500$56.75$12.97M897,625Dec 14, 2023Dec 15, 2023 ↗View →
IRON
DISC MEDICINE, INC.
SALE
14,100$58.56$825.7K281,505Dec 13, 2023Dec 14, 2023 ↗View →
IRON
DISC MEDICINE, INC.
SALE
36,400$58.56$2.13M727,907Dec 13, 2023Dec 14, 2023 ↗View →
IRON
DISC MEDICINE, INC.
SALE
56,200$58.56$3.29M1,126,225Dec 13, 2023Dec 14, 2023 ↗View →
IRON
DISC MEDICINE, INC.
SALE
3,600$60.16$216.6K295,605Dec 12, 2023Dec 14, 2023 ↗View →
IRON
DISC MEDICINE, INC.
SALE
9,300$60.16$559.5K764,307Dec 12, 2023Dec 14, 2023 ↗View →
IRON
DISC MEDICINE, INC.
SALE
14,400$60.16$866.3K1,182,425Dec 12, 2023Dec 14, 2023 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
87,786$2.23$195.8K0Nov 22, 2023Nov 24, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
38,327$0.75$28.7K97,204Aug 15, 2023Aug 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
248,819$0.75$186.6K631,048Aug 15, 2023Aug 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
535,534$0.75$401.7K1,510,375Aug 15, 2023Aug 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
29,700$3.00$89.1K879,867Jul 31, 2023Aug 2, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
153,078$3.00$459.2K2,105,909Jul 31, 2023Aug 2, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
26,622$3.00$79.9K135,531Jul 31, 2023Aug 2, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
7,800$2.92$22.8K162,153Jul 25, 2023Jul 27, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
26,700$2.92$78.0K2,258,987Jul 25, 2023Jul 27, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
4,700$2.92$13.7K909,567Jul 25, 2023Jul 27, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
9,800$2.40$23.5K169,953Jul 13, 2023Jul 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
132,100$2.40$317.0K2,285,687Jul 13, 2023Jul 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
52,800$2.40$126.7K914,267Jul 13, 2023Jul 17, 2023 ↗View →
ACET
ADICET BIO, INC.
PURCHASE
250,000$2.09$522.5K646,657Jun 27, 2023Jun 29, 2023 ↗View →
ACET
ADICET BIO, INC.
PURCHASE
125,000$2.09$261.3K1,027,885Jun 27, 2023Jun 29, 2023 ↗View →
ACET
ADICET BIO, INC.
PURCHASE
58,000$2.09$121.2K748,054Jun 27, 2023Jun 29, 2023 ↗View →
ACET
ADICET BIO, INC.
PURCHASE
442,000$2.09$923.8K5,685,259Jun 27, 2023Jun 29, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
2,125——0May 17, 2023May 19, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
PURCHASE
2,125$4.28$9.1K8,663,349May 17, 2023May 19, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
660$1.97$1.3K179,753Apr 17, 2023Apr 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
8,878$1.97$17.5K2,417,787Apr 17, 2023Apr 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
3,551$1.97$7.0K967,067Apr 17, 2023Apr 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
2,091$1.86$3.9K180,413Apr 14, 2023Apr 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
28,110$1.86$52.3K2,426,665Apr 14, 2023Apr 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
11,245$1.86$20.9K970,618Apr 14, 2023Apr 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
3,784$1.82$6.9K981,863Apr 13, 2023Apr 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
703$1.82$1.3K182,504Apr 13, 2023Apr 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
9,459$1.82$17.2K2,454,775Apr 13, 2023Apr 17, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
119$1.81$215183,207Apr 12, 2023Apr 12, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
641$1.81$1.2K985,647Apr 12, 2023Apr 12, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
1,603$1.81$2.9K2,464,234Apr 12, 2023Apr 12, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
3,784$1.82$6.9K986,288Apr 11, 2023Apr 12, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
9,459$1.82$17.2K2,465,837Apr 11, 2023Apr 12, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
703$1.82$1.3K183,326Apr 11, 2023Apr 12, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
34,745$1.79$62.2K2,500,582Apr 10, 2023Apr 12, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
2,584$1.79$4.6K185,910Apr 10, 2023Apr 12, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
13,899$1.79$24.9K1,000,187Apr 10, 2023Apr 12, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
6,558$2.00$13.1K2,510,041Apr 6, 2023Apr 7, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
487$2.00$974186,613Apr 6, 2023Apr 7, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
2,620$2.00$5.2K1,003,971Apr 6, 2023Apr 7, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
4,687$2.18$10.2K187,100Apr 5, 2023Apr 7, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
25,220$2.18$55.0K1,006,591Apr 5, 2023Apr 7, 2023 ↗View →
GLTO
GALECTO, INC.
SALE
63,058$2.18$137.5K2,516,599Apr 5, 2023Apr 7, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
7,611,458——8,661,225Feb 23, 2023Feb 27, 2023 ↗View →
ELVN
ENLIVEN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
288,114——288,114Feb 23, 2023Feb 27, 2023 ↗View →
IRON
DISC MEDICINE, INC.
PURCHASE
14,329$23.00$329.6K299,205Feb 15, 2023Feb 17, 2023 ↗View →
IRON
DISC MEDICINE, INC.
PURCHASE
37,049$23.00$852.1K773,607Feb 15, 2023Feb 17, 2023 ↗View →
IRON
DISC MEDICINE, INC.
PURCHASE
57,318$23.00$1.32M1,196,825Feb 15, 2023Feb 17, 2023 ↗View →
IRON
DISC MEDICINE, INC.
PURCHASE
153,936——736,558Dec 29, 2022Jan 3, 2023 ↗View →
IRON
DISC MEDICINE, INC.
PURCHASE
284,876——284,876Dec 29, 2022Jan 3, 2023 ↗View →
IRON
DISC MEDICINE, INC.
PURCHASE
1,139,507——1,139,507Dec 29, 2022Jan 3, 2023 ↗View →
IRON
DISC MEDICINE, INC.
PURCHASE
582,622——582,622Dec 29, 2022Jan 3, 2023 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
137,931$7.25$1000.0K4,882,854Dec 23, 2022Dec 28, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
402,000$3.21$1.29M15,219,994Nov 8, 2022Nov 10, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
484,496$10.32$5.00M13,981,952Sep 16, 2022Sep 16, 2022 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
38,450——38,450Aug 16, 2022Aug 18, 2022 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
207,500——207,500Aug 16, 2022Aug 18, 2022 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
64,050——64,050Aug 16, 2022Aug 18, 2022 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
457,400$2.42$1.11M1,973,881Aug 16, 2022Aug 18, 2022 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
762,400$2.42$1.85M762,400Aug 16, 2022Aug 18, 2022 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
2,470,200$2.42$5.98M4,744,923Aug 16, 2022Aug 18, 2022 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
26,253$15.93$418.2K87,786May 26, 2022May 31, 2022 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
138,000$7.21$995.0K13,497,456May 18, 2022May 20, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
30,722$2.49$76.5K14,817,994May 13, 2022May 13, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
97,094$2.35$228.2K14,787,272May 12, 2022May 13, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
64,700$1.79$115.8K14,690,178May 11, 2022May 13, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
24,447$1.60$39.1K14,625,478May 10, 2022May 10, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
90,712$1.56$141.5K14,601,031May 9, 2022May 10, 2022 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
10,200$1.63$16.6K14,510,319May 6, 2022May 10, 2022 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
34,500$21.17$730.4K0Mar 31, 2022Mar 31, 2022 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
75,000$22.39$1.68M34,500Mar 30, 2022Mar 31, 2022 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
365,000$21.52$7.85M109,500Mar 29, 2022Mar 31, 2022 ↗View →
JANX
JANUX THERAPEUTICS, INC.
SALE
3,700$20.30$75.1K231,098Dec 29, 2021Dec 30, 2021 ↗View →
JANX
JANUX THERAPEUTICS, INC.
SALE
36,700$20.30$745.0K2,258,566Dec 29, 2021Dec 30, 2021 ↗View →
JANX
JANUX THERAPEUTICS, INC.
SALE
11,100$19.00$210.9K234,798Dec 21, 2021Dec 23, 2021 ↗View →
JANX
JANUX THERAPEUTICS, INC.
SALE
108,300$19.00$2.06M2,295,266Dec 21, 2021Dec 23, 2021 ↗View →
JANX
JANUX THERAPEUTICS, INC.
SALE
356,800$19.07$6.80M2,403,566Dec 16, 2021Dec 17, 2021 ↗View →
JANX
JANUX THERAPEUTICS, INC.
SALE
36,500$19.07$696.1K245,898Dec 16, 2021Dec 17, 2021 ↗View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
214,285$14.00$3.00M242,285Dec 10, 2021Dec 14, 2021 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
3,571,428$3.50$12.50M3,571,428Nov 4, 2021Nov 8, 2021 ↗View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
1,785,715$3.50$6.25M14,500,119Nov 4, 2021Nov 8, 2021 ↗View →
JANX
JANUX THERAPEUTICS, INC.
SALE
643,046——0Jun 15, 2021Jun 16, 2021 ↗View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASE
1,348,421——1,348,421Jun 15, 2021Jun 16, 2021 ↗View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASE
823,742——2,172,163Jun 15, 2021Jun 16, 2021 ↗View →
JANX
JANUX THERAPEUTICS, INC.
SALE
1,052,632——0Jun 15, 2021Jun 16, 2021 ↗View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASE
164,748——164,748Jun 15, 2021Jun 16, 2021 ↗View →
JANX
JANUX THERAPEUTICS, INC.
SALE
128,609——0Jun 15, 2021Jun 16, 2021 ↗View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASE
117,650$17.00$2.00M282,398Jun 15, 2021Jun 16, 2021 ↗View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASE
588,203$17.00$10.00M2,760,366Jun 15, 2021Jun 16, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
312,500$16.00$5.00M13,359,456Mar 30, 2021Mar 31, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
46,875$16.00$750.0K319,599Mar 30, 2021Mar 31, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
272,724——272,724Mar 30, 2021Mar 31, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
1,572,960——0Mar 30, 2021Mar 31, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
8,187,100——0Mar 30, 2021Mar 31, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
272,724——0Mar 30, 2021Mar 31, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
1,668,350——0Mar 30, 2021Mar 31, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
12,730,036——13,046,956Mar 30, 2021Mar 31, 2021 ↗View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
1,301,626——0Mar 30, 2021Mar 31, 2021 ↗View →
GLTO
GALECTO, INC.
PURCHASE
822,311——822,311Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
SALE
31,147——0Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
PURCHASE
2,055,824——2,055,824Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
SALE
109,013——0Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
SALE
272,533——0Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
SALE
148,395——0Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
SALE
59,350——0Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
SALE
291,999——0Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
SALE
73,773——0Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
SALE
116,800——0Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
PURCHASE
209,500$15.00$3.14M1,031,811Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
PURCHASE
523,833$15.00$7.86M2,579,657Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
SALE
77,866——0Nov 2, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
PURCHASE
191,787——191,787Nov 2, 2020Nov 4, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
1,076,891——5,576,967Sep 29, 2020Sep 29, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
114,039——0Sep 29, 2020Sep 29, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
4,025,076——0Sep 29, 2020Sep 29, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
380,133——0Sep 29, 2020Sep 29, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
380,133——6,475,291Sep 29, 2020Sep 29, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
114,039——114,039Sep 29, 2020Sep 29, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
518,191——6,095,158Sep 29, 2020Sep 29, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
1,076,891——0Sep 29, 2020Sep 29, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
518,191——0Sep 29, 2020Sep 29, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
4,025,076——4,500,076Sep 29, 2020Sep 29, 2020 ↗View →
GLTO
GALECTO, INC.
SALEGRANT
Stock grant
148,395$27.11$4.02M148,395Sep 25, 2020Nov 4, 2020 ↗View →
GLTO
GALECTO, INC.
SALEGRANT
Stock grant
59,350$27.11$1.61M59,350Sep 25, 2020Nov 4, 2020 ↗View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
475,000$18.00$8.55M475,000Sep 25, 2020Sep 29, 2020 ↗View →
GLTO
GALECTO, INC.
SALEGRANT
Stock grant
73,773$27.11$2.00M73,773Sep 25, 2020Nov 4, 2020 ↗View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASE
744,612——744,612Apr 13, 2020Apr 13, 2020 ↗View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASE
148,922——148,922Apr 13, 2020Apr 13, 2020 ↗View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASE
375,200$16.00$6.00M1,119,812Apr 13, 2020Apr 13, 2020 ↗View →
KROS
KEROS THERAPEUTICS, INC.
SALE
744,612——0Apr 13, 2020Apr 13, 2020 ↗View →
KROS
KEROS THERAPEUTICS, INC.
SALE
148,922——0Apr 13, 2020Apr 13, 2020 ↗View →
Other insiders · ACET
Loading peer insiders…
About this filer
CIK 0001808744
ROLE
Director
PRIMARY
ACET
COMPANIES
18
ACTIVE SINCE
Apr 2020
MARKETPEEL · /INSIDER/0001808744DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback